Metabolic tumor volume on 18F-FDG uptake as a negative predictor after ipilimumab plus nivolumab in advanced non-small cell lung cancer.

論文 Metabolic tumor volume on 18F-FDG uptake as a negative predictor after ipilimumab plus nivolumab in advanced non-small cell lung cancer.

著者 Hashimoto K, Kaira K, Mouri A, Shiono A, Miura Y, Yamaguchi O, Imai H, Kagamu H, Kuji I.